Ectopically, expression of defined factors could reprogram mammalian somatic cells into induced pluripotent stem cells (iPSCs), which initiates a new strategy to obtain pluripotent stem cell lines. Attempts have been made to generate buffalo pluripotent stem cells by culturing primary germ cells or inner cell mass, but the efficiency is extremely low. Here, we report a successful method to reprogram buffalo fetal fibroblasts (BFFs) into pluripotent stem cells [buffalo induced pluripotent stem cell (biPSCs)] by transduction of buffalo defined factors (Oct4, Sox2, Klf4, and c-Myc) using retroviral vectors. The established biPSCs displayed typical morphological characteristics of pluripotent stem cells, normal karyotype, positive staining of alkaline phosphatase, and expressed pluripotent markers including Oct4, Sox2, Nanog, Lin28, E-Cadherin, SSEA-1, SSEA-4, TRA-1-81, STAT3, and FOXD3. They could form embryoid bodies (EBs) in vitro and teratomas after injecting into the nude BALB/C mice, and 3 germ layers were identified in the EBs and teratomas. Methylation assay revealed that the promoters of Oct4 and Nanog were hypomethylated in biPSCs compared with BFFs and pre-biPSCs, while the promoters of Sox2 and E-Cadherin were hypomethylated in both BFFs and biPSCs. Further, inhibiting p53 expression by coexpression of SV40 large T antigen and buffalo defined factors in BFFs or treating BFFs with p53 inhibitor pifithrin-a (PFT) could increase the efficiency of biPSCs generation up to 3-fold, and nuclear transfer embryos reconstructed with biPSCs could develop to blastocysts. These results indicate that BFFs can be reprogrammed into biPSCs by buffalo defined factors, and the generation efficiency of biPSCs can be increased by inhibition of p53 expression. These efforts will provide a feasible approach for investigating buffalo stem cell signal pathways, establishing buffalo stem cell lines, and producing genetic modification buffaloes in the future.
Get full access to this article
View all access options for this article.
References
1.
TakahashiK, YamanakaS. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
2.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK, YamanakaS. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
LiaoJ, CuiC, ChenS, RenJ, ChenJ, GaoY, LiH, JiaN, ChengL, XiaoH, XiaoL. 2009. Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell, 4:11–15.
6.
ShimadaH, NakadaA, HashimotoY, ShigenoK, ShionoyaY, NakamuraT. 2009. Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol Reprod Dev, 77:2.
7.
WuZ, ChenJ, RenJ, BaoL, LiaoJ, CuiC, RaoL, LiH, GuYet al.2009. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol, 1:46–54.
8.
EzashiT, TeluguBP, AlexenkoAP, SachdevS, SinhaS, RobertsRM. 2009. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci U S A, 106:10993–10998.
9.
HondaA, HiroseM, HatoriM, MatobaS, MiyoshiH, InoueK, OguraA. 2010. Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine. J Biol Chem, 285:31362–31369.
10.
BaoL, HeL, ChenJ, WuZ, LiaoJ, RaoL, RenJ, LiH, ZhuHet al.2011. Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors. Cell Res, 21:600–608.
WestFD, UhlEW, LiuY, StoweH, LuY, YuP, Gallegos-CardenasA, PrattSL, SticeSL. 2011. Brief report: chimeric pigs produced from induced pluripotent stem cells demonstrate germline transmission and no evidence of tumor formation in young pigs. Stem Cells, 29:1640–1643.
20.
HockemeyerD, SoldnerF, BeardC, GaoQ, MitalipovaM, DeKelverRC, KatibahGE, AmoraR, BoydstonEAet al.2009. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol, 27:851–857.
21.
ChengL, XiaoL. 2009. Pig induced pluripotent stem cells: a new resource for generating genetically modified pigs. Regen Med, 4:787–789.
22.
ShiD, LuF, WeiY, CuiK, YangS, WeiJ, LiuQ. 2007. Buffalos (Bubalus bubalis) cloned by nuclear transfer of somatic cells. Biol Reprod, 77:285–291.
23.
ClarkAJ. 1998. The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins. J Mammary Gland Biol Neoplasia, 3:337–350.
24.
ThomasKR, CapecchiMR. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell, 51:503–512.
25.
SkarnesWC, RosenB, WestAP, KoutsourakisM, BushellW, IyerV, MujicaAO, ThomasM, HarrowJet al.2011. A conditional knockout resource for the genome-wide study of mouse gene function. Nature, 474:337–342.
26.
EvansMJ, KaufmanMH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature, 292:154–156.
27.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS, JonesJM. 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
28.
ThomsonJA, KalishmanJ, GolosTG, DurningM, HarrisCP, BeckerRA, HearnJP. 1995. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A, 92:7844–7848.
29.
BuehrM, MeekS, BlairK, YangJ, UreJ, SilvaJ, McLayR, HallJ, YingQL, SmithA. 2008. Capture of authentic embryonic stem cells from rat blastocysts. Cell, 135:1287–1298.
GeorgeA, SharmaR, SinghKP, PandaSK, SinglaSK, PaltaP, ManikR, ChauhanMS. 2011. Production of cloned and transgenic embryos using buffalo (Bubalus bubalis) embryonic stem cell-like cells isolated from in vitro fertilized and cloned blastocysts. Cell Reprogram, 13:263–272.
32.
HuangB, LiT, WangXL, XieTS, LuYQ, da SilvaFM, ShiDS. 2009. Generation and characterization of embryonic stem-like cell lines derived from in vitro fertilization Buffalo (Bubalus bubalis) embryos. Reprod Domest Anim, 45:122–128.
33.
TeluguBP, EzashiT, RobertsRM. 2009. The promise of stem cell research in pigs and other ungulate species. Stem Cell Rev, 6:31–41.
34.
LilyestromW, KleinMG, ZhangR, JoachimiakA, ChenXS. 2006. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev, 20:2373–2382.
35.
ParkIH, ZhaoR, WestJA, YabuuchiA, HuoH, InceTA, LerouPH, LenschMW, DaleyGQ. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451:141–146.
36.
MaliP, YeZ, HommondHH, YuX, LinJ, ChenG, ZouJ, ChengL. 2008. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells, 26:1998–2005.
37.
HuangB, XieTS, ShiDS, LiT, WangXL, MoY, WangZQ, LiMM. 2007. Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)Cell Biol Int, 31:1079–1088.
38.
LiR, LiangJ, NiS, ZhouT, QingX, LiH, HeW, ChenJ, LiFet al.2010. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 7:51–63.
39.
Samavarchi-TehraniP, GolipourA, DavidL, SungHK, BeyerTA, DattiA, WoltjenK, NagyA, WranaJL. 2010. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell, 7:64–77.
UtikalJ, PoloJM, StadtfeldM, MaheraliN, KulalertW, WalshRM, KhalilA, RheinwaldJG, HochedlingerK. 2009. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature, 460:1145–1148.
42.
HongH, TakahashiK, IchisakaT, AoiT, KanagawaO, NakagawaM, OkitaK, YamanakaS. 2009. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 460:1132–1135.
43.
LiH, ColladoM, VillasanteA, StratiK, OrtegaS, CanameroM, BlascoMA, SerranoM. 2009. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature, 460:1136–1139.
44.
HannaJ, SahaK, PandoB, van ZonJ, LengnerCJ, CreyghtonMP, van OudenaardenA, JaenischR. 2009. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature, 462:595–601.
45.
AgarwalS, LohYH, McLoughlinEM, HuangJ, ParkIH, MillerJD, HuoH, OkukaM, Dos ReisRMet al.2010. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature, 464:292–296.
KitamuraT, KoshinoY, ShibataF, OkiT, NakajimaH, NosakaT, KumagaiH. 2003. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol, 31:1007–1014.
48.
MaheraliN, HochedlingerK. 2008. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell, 3:595–605.
49.
AoiT, YaeK, NakagawaM, IchisakaT, OkitaK, TakahashiK, ChibaT, YamanakaS. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321:699–702.
50.
SilvaJ, NicholsJ, TheunissenTW, GuoG, van OostenAL, BarrandonO, WrayJ, YamanakaS, ChambersI, SmithA. 2009. Nanog is the gateway to the pluripotent ground state. Cell, 138:722–737.
QinH, YuT, QingT, LiuY, ZhaoY, CaiJ, LiJ, SongZ, QuXet al.2007. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem, 282:5842–5852.
57.
ZhouY, ZhenH, MeiY, WangY, FengJ, XuS, FuX. 2009. PI3K/AKT mediated p53 down-regulation participates in CpG DNA inhibition of spontaneous B cell apoptosis. Cell Mol Immunol, 6:175–180.
58.
LiY, CangM, LeeAS, ZhangK, LiuD. 2011. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS One, 6:e15947.
SharmaR, GeorgeA, KambleNM, SinghKP, ChauhanMS, SinglaSK, ManikRS, PaltaP. 2011. Optimization of culture conditions to support long term self-renewal of buffalo (Bubalus bubalis) embryonic stem cell like cells. Cell Reprogram, 13:539–548.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
